Perrigo | PRGO - Operating Profit


Perrigo reported $93.4M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Abbott USD 2.25B 73M Dec/2025
Bayer EUR -543M 556M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Coherus Biosciences USD -45.43M 3.13M Mar/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Merck USD 6.24B 318M Dec/2025
Nestle CHF 7.14B 689M Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Phibro Animal Health USD 25.53M 7.83M Dec/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Reckitt Benckiser GBP 747M 92M Dec/2024
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025
Zoetis USD 835M 101M Dec/2025